PACIRA BIOSCIENCES, INC. Goodwill
PACIRA BIOSCIENCES, INC. (PCRX) had Goodwill of $19.64 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2026-08-04
- 2026-06-30: Goodwill $19.64M.
- 2026-03-31: Goodwill $19.77M.
- 2025-12-31: Goodwill $20.21M.
- 2025-09-30: Goodwill $20.32M.
| Period end | Goodwill | Goodwill as first filed |
|---|---|---|
| 2026-06-30 | $19.64M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $19.77M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $20.21M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $20.32M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $20.30M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $21.52M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $163.24M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $163.24M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $163.24M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $163.24M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $163.24M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $163.24M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $163.24M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $157.36M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $146.13M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $145.72M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $145.20M 10-K · filed 2024-02-29 | $145.18M 10-K · filed 2022-02-28 |
| 2021-09-30 | $99.55M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $99.55M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $99.55M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $99.55M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $99.55M 10-Q · filed 2020-10-30 | |
| 2020-06-30 | $99.55M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $99.55M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $99.55M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $99.55M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $100.54M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $62.04M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $62.04M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $62.04M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $59.91M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $57.49M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $55.20M 10-K · filed 2020-02-21 | |
| 2017-09-30 | $52.96M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $50.94M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $48.83M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $46.74M 10-K · filed 2019-02-28 | |
| 2016-09-30 | $44.67M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $42.75M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $32.78M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $30.88M 10-K · filed 2018-02-28 | |
| 2015-09-30 | $28.89M 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $27.12M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $25.38M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $23.76M 10-K · filed 2017-03-01 | |
| 2014-09-30 | $22.05M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $12.52M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $11.33M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $10.33M 10-K · filed 2016-02-25 | |
| 2013-09-30 | $9.54M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $8.98M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $8.58M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $8.30M 10-K · filed 2015-02-24 | |
| 2012-09-30 | $8.11M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $7.99M 10-Q · filed 2012-08-09 | |
| 2012-04-30 | $8.00M 10-Q · filed 2018-08-02 | |
| 2011-12-31 | $0.00 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |